Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(R)-CHOP vs (R)-CVP in Elderly Patients with Diffuse Large B-cell Lymphoma
NCT03513601Phase 4Unknown
- Start
- Jul 2017
- Primary completion
- May 2019
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab, cyclophosphamide, epirubicin, vincristine, prednisone in diffuse large B-cell lymphoma (DLBCL). Status: unknown.
02
Drugs
rituximabcyclophosphamideepirubicinvincristineprednisone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03513601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513601.